Cargando…
Correction: Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications
Autores principales: | Boff da Costa, Raquel, Boff Costa, Marisa, Longo, Larisse, Miotto, Daniela Elisa, Hirata Dellavia, Gustavo, Trucollo Michalczuk, Matheus, Alvares-da-Silva, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126410/ https://www.ncbi.nlm.nih.gov/pubmed/35604903 http://dx.doi.org/10.1371/journal.pone.0269049 |
Ejemplares similares
-
Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications
por: Boff da Costa, Raquel, et al.
Publicado: (2021) -
Seroprevalence of hepatitis E virus in risk populations and blood donors in a referral hospital in the south of Brazil
por: Costa, Marisa Boff, et al.
Publicado: (2021) -
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
por: Hsu, Po-Yao, et al.
Publicado: (2021) -
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
por: Marzolini, Catia, et al.
Publicado: (2022) -
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)